Porsche SE invests in specialist for health and performance monitoring of semiconductors

New investment expands portfolio / proteanTecs offers a technology platform to monitor the reliability of semiconductors over the entire lifecycle

Stuttgart, 23 September 2021. Porsche Automobil Holding SE (Porsche SE), Stuttgart, further expands its portfolio with the investment in proteanTecs Ltd., Haifa, Israel. The technology of the company which was founded in 2017 allows the monitoring of health and performance of semiconductors and electronic systems over the entire lifecycle from design to operation.

The solution developed by proteanTecs combines a software platform based on machine learning with specially developed so-called Agents, which are already integrated in the semiconductor design process and serve as sensors in the semiconductor. The read out and analysis of the obtained data provides insights into the health and performance of semiconductors and electronic systems. Especially for new semiconductor generations, these insights can be used to increase quality and reliability and extend the lifespan, resulting in cost-savings along the entire semiconductor value chain. proteanTecs has already won renowned customers for its technology in relevant segments.

Lutz Meschke, member of the board of management responsible for investment management at Porsche SE: “Due to the fast-paced technological advancements and the ever-growing requirements for new chip generations, there is an enormous market potential for the technology of proteanTecs. We see benefits and the necessity for the use of this technology in many areas, including the automotive industry.”

The investment was made in a financing round in which proteanTecs raised an additional 50 million US dollars. In addition to the investment from Porsche SE, proteanTecs has thus raised a total of 150 million US dollars from investors including Advantest, MediaTek, Intel Capital, Koch Disruptive Technologies, Viola Ventures and Celesta. The company expands Porsche SE’s portfolio of future-oriented venture capital investments. proteanTecs will use the proceeds from the financing round in particular to enlarge its sales organization and to further refine its technology.